0001453687-24-000050.txt : 20240328 0001453687-24-000050.hdr.sgml : 20240328 20240328171138 ACCESSION NUMBER: 0001453687-24-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240117 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPRINGER TIMOTHY A CENTRAL INDEX KEY: 0001055624 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37798 FILM NUMBER: 24800304 MAIL ADDRESS: STREET 1: 36 WOODMAN ROAD CITY: CHESTNUT HILL STATE: MA ZIP: 02467 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cartesian Therapeutics, Inc. CENTRAL INDEX KEY: 0001453687 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 GROVE STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-923-1400 MAIL ADDRESS: STREET 1: 65 GROVE STREET CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: SELECTA BIOSCIENCES INC DATE OF NAME CHANGE: 20090109 4 1 wk-form4_1711660282.xml FORM 4 X0508 4 2024-01-17 0 0001453687 Cartesian Therapeutics, Inc. RNAC 0001055624 SPRINGER TIMOTHY A 36 WOODMAN ROAD CHESTNUT HILL MA 02467 1 0 1 0 0 Common Stock 2024-01-17 4 P 0 800 0.69 A 87218 I By wife Common Stock 2024-02-06 4 P 0 800 0.65 A 88018 I By wife Common Stock 2024-02-07 4 P 0 2400 0.6563 A 90418 I By wife Common Stock 2024-03-08 4 P 0 4800 0.6639 A 95218 I By wife Common Stock 2024-03-11 4 P 0 1200 0.6541 A 96418 I By wife Common Stock 2024-03-12 4 P 0 1200 0.6122 A 97618 I By wife Common Stock 2024-03-13 4 P 0 3200 0.5837 A 100818 I By wife Common Stock 2024-03-14 4 P 0 2000 0.5305 A 102818 I By wife Common Stock 2024-03-15 4 P 0 1200 0.56 A 104018 I By wife Common Stock 2024-03-18 4 P 0 800 0.61 A 104818 I By wife Common Stock 7471625 D Common Stock 33043849 I See Footnote The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.65 to $0.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.65 to $0.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.65 to $0.66. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.61 to $0.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.58 to $0.59. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.52 to $0.54. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any. /s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer 2024-03-28